Compassionate Use of a Single Dose of Benralizumab in a Near-Fatal Asthma Exacerbation

被引：7

作者：

Perez de Llano, L. ^{[1
,2
]}

Blanco Cid, N. ^{[1
,2
]}

Ortiz Piquer, M. ^{[2
,3
]}

Dacal Rivas, D. ^{[1
,2
]}

机构：

[1] Hosp Lucus Augusti Lugo, Pneumol Serv, Lugo, Spain

[2] EOXI Lugo, Lugo, Spain

[3] Hosp Lucus Augusti Lugo, Intens Care Unit, Lugo, Spain

来源：

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2021年 / 31卷 / 03期

关键词：

Asthma; Benralizumab; Asthma attack; Asthma exacerbation;

D O I：

10.18176/jiaci.0609

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：268 / +

页数：3

共 10 条

[1] Risk factors, management and outcomes of patients admitted with near fatal asthma to a tertiary care hospital in Riyadh [J].

Al-Dorzi, Hasan M. ;

Al-Shammary, Haifa A. ;

Al-Shareef, Salha Y. ;

Tamim, Hani M. ;

Shammout, Khaled ;

Al Dawood, Abdulaziz ;

Arabi, Yaseen M. .

ANNALS OF THORACIC MEDICINE, 2014, 9 (01) :33-38

[2] Oral corticosteroids in poorly controlled asthma [J].

Colice, GL ;

Stampone, P ;

Leung, DYM ;

Szefler, SJ .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (01) :200-201

[3] Benralizumab: A New Approach for the Treatment of Severe Eosinophilic Asthma [J].

Gonzalez I, Davila ;

Benitez F, Moreno ;

Quirce, S. .

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (02) :84-93

[4] Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia [J].

Laviolette, Michel ;

Gossage, David L. ;

Gauvreau, Gail ;

Leigh, Richard ;

Olivenstein, Ron ;

Katial, Rohit ;

Busse, William W. ;

Wenzel, Sally ;

Wu, Yanping ;

Datta, Vivekananda ;

Kolbeck, Roland ;

Molfino, Nestor A. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (05) :1086-+

[5] Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma [J].

Nair, Parameswaran ;

Wenzel, Sally ;

Rabe, Klaus F. ;

Bourdin, Arnaud ;

Lugogo, Njira L. ;

Kuna, Piotr ;

Barker, Peter ;

Sproule, Stephanie ;

Ponnarambil, Sandhia ;

Goldman, Mitchell .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (25) :2448-2458

[6] A randomized trial of benralizumab, an antiinterleukin 5 receptor α monoclonal antibody, after acute asthma [J].

Nowak, Richard M. ;

Parker, Joseph M. ;

Silverman, Robert A. ;

Rowe, Brian H. ;

Smithline, Howard ;

Khan, Faiz ;

Fiening, Jon P. ;

Kim, Keunpyo ;

Molfino, Nestor A. .

AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2015, 33 (01) :14-20

[7] Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme [J].

Nwaru, Bright I. ;

Ekstrom, Magnus ;

Hasvold, Pal ;

Wiklund, Fredrik ;

Telg, Gunilla ;

Janson, Christer .

EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (04)

[8] The Use of Benralizumab in the Treatment of Near-Fatal Asthma: A New Approach [J].

Ramakrishnan, Sanjay ;

Camp, James R. ;

Vijayakumar, Bavithra ;

Hardinge, Frances M. ;

Downs, Matilda L. ;

Russell, Richard E. K. ;

Pavord, Ian D. ;

Bafadhel, Mona .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (11) :1441-1443

[9]

Ryman JT, 2017, CPT-PHARMACOMET SYST, V6, P576, DOI 10.1002/psp4.12224

[10] Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussion [J].

Tello, Khodr ;

Hoffmann, Andreas ;

Beutel, Bjoern ;

Greulich, Timm ;

Vogelmeier, Claus Franz ;

Richter, Manuel Jonas ;

Kuhnert, Stefan ;

Boeselt, Tobias ;

Alter, Peter ;

Holland, Angelique ;

Idzko, Marco ;

Buhl, Roland ;

Koczulla, Andreas Rembert .

RESPIRATORY MEDICINE CASE REPORTS, 2019, 28

← 1 →